FilingPulse

TNXP insider transaction filings

Tonix Pharmaceuticals Holding Corp. — 39 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-09. Screen TNXP transaction legs live →

FiledFormInsiderReported transactionsSource
2026-07-094SAENGER BRADLEY — Chief Financial OfficerOther (J): 1,453 @ $10.91EDGAR
2026-06-154Taylor Carolyn E. — DirectorPurchase (P): 1,415 @ $10.55EDGAR
2026-06-094LEDERMAN SETH — Chief Executive Officer, DirectorPurchase (P): 5,000 @ $11.79EDGAR
2026-06-094Stillwell Richard Newcomb — DirectorPurchase (P): 5,000 @ $11.65EDGAR
2026-05-144Stillwell Richard Newcomb — DirectorGrant/award (A): 22,700 (derivative) @ $0EDGAR
2026-05-144Bell Margaret Smith — DirectorGrant/award (A): 22,700 (derivative) @ $0EDGAR
2026-05-144Hunter James Randolph Jr — DirectorGrant/award (A): 22,700 (derivative) @ $0EDGAR
2026-05-144Treco James — DirectorGrant/award (A): 22,700 (derivative) @ $0EDGAR
2026-05-144Taylor Carolyn E. — DirectorGrant/award (A): 22,700 (derivative) @ $0EDGAR
2026-05-144BAGGER RICHARD H — DirectorGrant/award (A): 22,700 (derivative) @ $0EDGAR
2026-05-144GRANGE DAVID L — DirectorGrant/award (A): 22,700 (derivative) @ $0EDGAR
2026-05-144OLUKOTUN ADEOYE Y — DirectorGrant/award (A): 22,700 (derivative) @ $0EDGAR
2026-04-014LEDERMAN SETH — Chief Executive Officer, DirectorPurchase (P): 5,000 @ $12.62EDGAR
2026-03-184LEDERMAN SETH — Chief Executive Officer, DirectorPurchase (P): 15,000 @ $14.89EDGAR
2026-02-264MORRIS JESSICA EDGAR — Chief Operating OfficerGrant/award (A): 39,012 (derivative) @ $0 · Grant/award (A): 39,011 (derivative) @ $0EDGAR
2026-02-264SAENGER BRADLEY — Chief Financial OfficerGrant/award (A): 39,012 (derivative) @ $0 · Grant/award (A): 39,011 (derivative) @ $0EDGAR
2026-02-264SULLIVAN GREGORY M — Chief Medical OfficerGrant/award (A): 39,012 (derivative) @ $0 · Grant/award (A): 39,011 (derivative) @ $0EDGAR
2026-02-264Fogarty Siobhan — Chief Technology OfficerGrant/award (A): 39,012 (derivative) @ $0 · Grant/award (A): 39,011 (derivative) @ $0EDGAR
2026-02-264LEDERMAN SETH — Chief Executive Officer, DirectorGrant/award (A): 134,504 (derivative) @ $0 · Grant/award (A): 134,503 (derivative) @ $0EDGAR
2025-08-214Taylor Carolyn E. — DirectorPurchase (P): 418 @ $36.03EDGAR
2025-08-204Treco James — DirectorPurchase (P): 250 @ $36EDGAR
2025-06-134Hunter James Randolph Jr — DirectorGrant/award (A): 7,740 (derivative) @ $0EDGAR
2025-05-154LEDERMAN SETH — Chief Executive Officer, DirectorPurchase (P): 4,000 @ $21.55EDGAR
2025-05-154Treco James — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-05-154Bell Margaret Smith — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-05-154Taylor Carolyn E. — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-05-154Stillwell Richard Newcomb — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-05-154BAGGER RICHARD H — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-05-154GRANGE DAVID L — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-05-154OLUKOTUN ADEOYE Y — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-02-284Bell Margaret Smith — DirectorOther (J): 1 @ $0.15EDGAR
2025-02-284Treco James — DirectorOther (J): 0.02 @ $0.30EDGAR
2025-02-284BAGGER RICHARD H — DirectorOther (J): 0.02 @ $0.20EDGAR
2025-02-284OLUKOTUN ADEOYE Y — DirectorOther (J): 0.81 @ $1.91EDGAR
2025-02-274SAENGER BRADLEY — Chief Financial OfficerOther (J): 0.04 @ $0 · Grant/award (A): 25,792 (derivative) @ $0 · Grant/award (A): 25,792 (derivative) @ $0EDGAR
2025-02-274SULLIVAN GREGORY M — Chief Medical OfficerOther (J): 0.11 @ $1.47 · Grant/award (A): 29,017 (derivative) @ $0 · Grant/award (A): 29,017 (derivative) @ $0EDGAR
2025-02-274LEDERMAN SETH — Chief Executive Officer, DirectorOther (J): 5.18 @ $3.38 · Other (J): 0.22 @ $3.30 · Other (J): 1 @ $0.15 · Grant/award (A): 123,958 (derivative) @ $0 · Grant/award (A): 123,958 (derivative) @ $0EDGAR
2025-02-274MORRIS JESSICA EDGAR — Chief Operating OfficerOther (J): 1 @ $0 · Grant/award (A): 29,291 (derivative) @ $0 · Grant/award (A): 29,291 (derivative) @ $0EDGAR
2025-02-274Fogarty Siobhan — Chief Technology OfficerGrant/award (A): 13,500 (derivative) @ $0 · Grant/award (A): 13,500 (derivative) @ $0EDGAR

Recent 8-K events — Tonix Pharmaceuticals Holding Corp.

FiledFormItems reportedSource
2026-08-188-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events		EDGAR
2026-08-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-08-038-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-07-218-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-07-138-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-298-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-088-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-05-278-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-05-158-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-05-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=TNXP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →